Table 2.

Disease history of IBD patients that use CAM.

Disease duration n = 193 (%)
<12 months	1 (1.2)
1-5 years	18 (9.0)
6-10 years	45 (23.3)
11-20 years	71 (36.8)
>20 years	58 (30.1)
Medical therapy n = 193 (%)
Steroids (n = 191)	9 (5.0)
5-ASA derivatives	42 (21.8)
Azathioprine/methotrexate	9 (5.0)
Anti-TNF	52 (26.9)
Newer agents	79 (40.9)
Combination	6 (3.0)
No advanced therapy	50 (25.9)
Hospitalizations n = 158 (%)
None	51 (32.3)
Within past month	1 (1.0)
Within past 12 months	4 (3.0)
Within past 5 years	36 (22.8)
Within past 10 years	66 (41.8)
Surgeries n = 193 (%)
None	109 (56.5)
1	63 (32.6)
2	9 (4.6)
3 or more	12 (10.8)